Mithril Capital Management — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

Avitideavitide.comAug 2018acquired by Repligen

Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.

BiotechHardwareMedical DevicesLebanon, US

Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)

Board seatAjay Royan· per SEC Form D

Co-investorsOrbiMed SV Health Investors Borealis Ventures Neomed Management Polaris Partners Sands Capital Ventures +1 more

GreyOrangegreyorange.com in 𝕏Series C · Sep 2018 · $140M

GreyOrange provides AI-driven supply chain orchestration and inventory optimization software for retailers and third-party logistics providers.

AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainRobotics

Akash Gupta(Founder)inSamay Kohli(Founder)

Co-investorsInventus Capital Partners NB Ventures Blume Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Capture2

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.